RWEpi
Real World Epidemiology Research Group (RWEpi)

RESPONSABLE DEL GRUP
avatar_investigadors.jpg
Talita Duarte Salles
avatar_grups_recerca.png

Publicacions

Development and external validation of a 1-and 5-year fracture prediction tool based on electronic medical records data: The EPIC risk algorithm

C. TEBE, N. PALLARES, C. REYES, C. CARBONELL-ABELLA, D. MONTERO-COROMINAS, E. MARTIN-MERINO, X. NOGUES, A. DIEZ-PEREZ, D. PRIETO-ALHAMBRA and D. MARTINEZ-LAGUNA
BONE. 2022 Sep 1; . doi:10.1016/j.bone.2022.116469; PMID:35691583

Secular trends of dispensed opioid prescriptions in Catalonia, Spain, 2007-19: A population-based cohort study of over 5 million individuals

J. XIE, V. STRAUSS, G. COLLINS, S. KHALID, A. DELMESTRI, A. TURKIEWICZ, M. ENGLUND, M. TADROUS, C. REYES and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

The impact of COVID-19 on population-level drug utilization of alendronate in five European databases

E. TAN, D. ROBINSON, A. JOEDICKE, M. SANCHEZ-SANTOS, M. MOSSEVELD, K. NIELSEN, C. REYES, A. VOSS, E. MARCONI, F. LAPI, J. REINOLD, K. VERHAMME, L. PEDERSEN, M. DE WILDE, M. RUIZ, M. ARAGON, P. BOSCO-LEVY, R. LASSALLE and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

The comparative risk of thrombosis with thrombocytopenia associated with different COVID-19 vaccines: International network cohort study including 5 European countries and the US

X. LI, E. BURN, T. DUARTE-SALLES, C. YIN, C. REICH, A. DELMESTRI, K. VERHAMME, P. RIJNBEEK and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Overlap weighting versus inverse probability of treatment weighting: An empirical evaluation of propensity score methods to minimize confounding in COVID-19 vaccine effectiveness studies

A. JOEDICKE, M. CATALA, E. BURN, T. RATHOD-MISTRY, A. DELMESTRI and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Patronat

Col·laboradors

Acreditacions